JAZZ News and Press, Jazz Pharmaceuticals plc From 09/22/19

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you c...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

DUBLIN , Sept. 18, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will host a webcast on Wednesday, September 25, 2019 at 9:00 p.m. EDT /2:00 a.m. IST ( September 26 , 2019) to provide investors with a business update, inclu...

Company Thesis Jazz Pharmaceuticals' ( JAZZ ) blockbuster drug Xyrem will be fighting a two-front war as both branded and generic competitors have seen their products enter the U.S. narcolepsy market without infringing on the company's patents. Over 75% of JAZZ's revenues are derived from...

This article is part of a series that provides an ongoing analysis of the changes made to Ole Andreas Halvorsen's 13F stock portfolio on a quarterly basis. It is based on Viking Global's regulatory 13F Form filed on 08/14/2019. Please visit our Tracking Ole Andreas Halvorsen's Viking Global...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

The FDA approves privately held Harmony Biosciences, LL C's WAKIX (pitolisant) for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. More news on: Jazz Pharmaceuticals plc, Endo International plc, Healthcare stocks news, Read more ...

Investment Thesis Bausch Health Companies ( BHC ) delivered an inline Q2 2019 with modest top and bottom lines growth. The company has a portfolio of diversified products that should continue to deliver growth despite losses of exclusivity in a few products in the near-term. However, it has ...

Jazz Pharmaceuticals (NASDAQ: JAZZ ) has acquired privately held clinical-stage biotech Cavion for up to $312.5M, consisting of $52.5M upfront and up to $260.0M in milestones. More news on: Jazz Pharmaceuticals plc, Healthcare stocks news, Merger & acquisition news, Read more ....